Newswise — TAMPA, Fla. — Anti-cancer immune cells are critical to inhibiting the development and progression of tumors, and deregulation of the immune system can limit the ability of immune cells to identify and target cancer cells for destruction.
2022
IO Before BRAK/MEK Inhibition Is the Ideal Treatment Sequence for BRAF-Mutant Melanoma
Data from the DREAMseq trial have answered a lingering question of how to sequence therapy for patients with advanced BRAF-mutant melanoma. This research supports immunotherapy in the first-line setting, followed by BRAK/MEK inhibitors.
Aussie schoolboy dies from rare melanoma not caused by the sun
A Sunshine Coast schoolboy is being remembered for his bravery after losing his fight with a very rare melanoma.
Mediterranean diet improves immunotherapy response rates and progression-free survival in advanced melanoma, new study suggests
(Vienna, October 9, 2022) Eating a Mediterranean diet, rich in fibre, mono-unsaturated fatty acids and polyphenols, has been associated with improved immunotherapy response rates and progression-free survival in advanced melanoma patients, a new study presented today at UEG Week 2022 has found.